Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

CCR 20th anniversary commentary: a chimeric antibody, C225, inhibits EGFR activation and tumor growth.

Mendelsohn J, Prewett M, Rockwell P, Goldstein NI.

Clin Cancer Res. 2015 Jan 15;21(2):227-9. doi: 10.1158/1078-0432.CCR-14-2491.

2.

Surface-epitope masking (SEM): an immunological subtraction approach for developing monoclonal antibodies targeting surface-expressed molecules.

Goldstein NI, Fisher PB.

Methods Mol Biol. 2007;383:245-58. doi: 10.1007/978-1-59745-335-6_16.

PMID:
18217690
3.

The use of phage display peptide libraries for basic and translational research.

Brissette R, Goldstein NI.

Methods Mol Biol. 2007;383:203-13. doi: 10.1007/978-1-59745-335-6_13. Review.

PMID:
18217687
4.

Identification of cancer targets and therapeutics using phage display.

Brissette R, Prendergast JK, Goldstein NI.

Curr Opin Drug Discov Devel. 2006 May;9(3):363-9. Review.

PMID:
16729733
5.

Assembly of high-affinity insulin receptor agonists and antagonists from peptide building blocks.

Schäffer L, Brissette RE, Spetzler JC, Pillutla RC, Østergaard S, Lennick M, Brandt J, Fletcher PW, Danielsen GM, Hsiao KC, Andersen AS, Dedova O, Ribel U, Hoeg-Jensen T, Hansen PH, Blume AJ, Markussen J, Goldstein NI.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4435-9. Epub 2003 Apr 8.

6.

Peptides identify multiple hotspots within the ligand binding domain of the TNF receptor 2.

Hsiao KC, Brissette RE, Wang P, Fletcher PW, Rodriguez V, Lennick M, Blume AJ, Goldstein NI.

Proteome Sci. 2003 Jan 24;1(1):1.

7.

Target validation and drug discovery using genomic and protein-protein interaction technologies.

Pillutla RC, Fisher PB, Blume AJ, Goldstein NI.

Expert Opin Ther Targets. 2002 Aug;6(4):517-31. Review.

PMID:
12223066
8.

Peptides identify the critical hotspots involved in the biological activation of the insulin receptor.

Pillutla RC, Hsiao KC, Beasley JR, Brandt J, Østergaard S, Hansen PH, Spetzler JC, Danielsen GM, Andersen AS, Brissette RE, Lennick M, Fletcher PW, Blume AJ, Schäffer L, Goldstein NI.

J Biol Chem. 2002 Jun 21;277(25):22590-4. Epub 2002 Apr 18.

9.

Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.

Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su Z, Lebedeva IV, Kang D, Jiang H, Lin JJ, Alexandre D, Chen Y, Vozhilla N, Mei MX, Christiansen KA, Sivo F, Goldstein NI, Mhashilkar AB, Chada S, Huberman E, Pestka S, Fisher PB.

Oncogene. 2001 Oct 25;20(48):7051-63.

10.

A surrogate-based approach for post-genomic partner identification.

Pillutla RC, Hsiao K, Brissette R, Eder PS, Giordano T, Fletcher PW, Lennick M, Blume AJ, Goldstein NI.

BMC Biotechnol. 2001;1:6. Epub 2001 Sep 25.

11.

A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells.

Su Z, Lebedeva IV, Gopalkrishnan RV, Goldstein NI, Stein CA, Reed JC, Dent P, Fisher PB.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10332-7.

12.

The use of peptides in Diogenesis: a novel approach to drug discovery and phenomics.

Blume AJ, Beasley J, Goldstein NI.

Biopolymers. 2000;55(4):347-56. Review.

PMID:
11169925
13.

Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy.

Madireddi MT, Su ZZ, Young CS, Goldstein NI, Fisher PB.

Adv Exp Med Biol. 2000;465:239-61. Review. No abstract available.

PMID:
10810631
14.

PEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesis.

Su ZZ, Goldstein NI, Jiang H, Wang MN, Duigou GJ, Young CS, Fisher PB.

Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15115-20.

17.
18.

Translational infidelity and human cancer: role of the PTI-1 oncogene.

Gopalkrishnan RV, Su ZZ, Goldstein NI, Fisher PB.

Int J Biochem Cell Biol. 1999 Jan;31(1):151-62. Review.

PMID:
10216950
19.

The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice.

Su ZZ, Madireddi MT, Lin JJ, Young CS, Kitada S, Reed JC, Goldstein NI, Fisher PB.

Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14400-5.

20.

Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.

Su Z, Goldstein NI, Fisher PB.

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1764-9.

21.

Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes.

Harding JA, Engbers CM, Newman MS, Goldstein NI, Zalipsky S.

Biochim Biophys Acta. 1997 Jul 25;1327(2):181-92.

22.

Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides.

Rockwell P, O'Connor WJ, King K, Goldstein NI, Zhang LM, Stein CA.

Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6523-8.

23.

The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma.

Prewett M, Rockwell P, Rockwell RF, Giorgio NA, Mendelsohn J, Scher HI, Goldstein NI.

J Immunother Emphasis Tumor Immunol. 1996 Nov;19(6):419-27.

PMID:
9041461
24.

The melanoma differentiation associated gene mda-7 suppresses cancer cell growth.

Jiang H, Su ZZ, Lin JJ, Goldstein NI, Young CS, Fisher PB.

Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9160-5.

25.

Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family.

Su ZZ, Lin J, Shen R, Fisher PE, Goldstein NI, Fisher PB.

Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7252-7.

26.
27.

Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.

Goldstein NI, Prewett M, Zuklys K, Rockwell P, Mendelsohn J.

Clin Cancer Res. 1995 Nov;1(11):1311-8.

28.

Isolation and characterization of a monoclonal antibody binding to the extracellular domain of the flk-2 tyrosine kinase receptor.

Rose C, Rockwell P, Yang JQ, Pytowski B, Goldstein NI.

Hybridoma. 1995 Oct;14(5):453-9.

PMID:
8575794
29.

Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate.

Jiang H, Lin J, Young SM, Goldstein NI, Waxman S, Davila V, Chellappan SP, Fisher PB.

Oncogene. 1995 Sep 21;11(6):1179-89.

PMID:
7566979
30.

Apoptosis mediates the selective toxicity of caffeic acid phenethyl ester (CAPE) toward oncogene-transformed rat embryo fibroblast cells.

Su ZZ, Lin J, Prewett M, Goldstein NI, Fisher PB.

Anticancer Res. 1995 Sep-Oct;15(5B):1841-8.

PMID:
8572568
31.

A novel antigen defined by monoclonal antibody CR101 is associated with small cell lung carcinoma.

Rose C, Waksal H, Goldstein NI.

Hybridoma. 1994 Jun;13(3):221-7.

PMID:
7927366
32.

Surface-epitope masking: a strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surface.

Shen R, Su ZZ, Olsson CA, Goldstein NI, Fisher PB.

J Natl Cancer Inst. 1994 Jan 19;86(2):91-8.

PMID:
7505832
33.

New approaches for the development and application of monoclonal antibodies for the diagnosis and therapy of human cancer.

Leon JA, Goldstein NI, Fisher PB.

Pharmacol Ther. 1994;61(1-2):237-78. Review.

PMID:
7938173
34.

Isolation of a monoclonal antibody to the TrpE protein and its use for the purification of recombinant fusion proteins.

Nurse F, Dagan S, Tackney C, Goldstein NI.

Hybridoma. 1991 Dec;10(6):753-60.

PMID:
1816074
35.

Isolation and characterization of a human monoclonal antibody which reacts with breast and colorectal carcinoma.

Goldstein NI, Nagle R, Villar H, Hersh E, Fisher PB.

Anticancer Res. 1990 Nov-Dec;10(6):1491-500.

PMID:
1704693
37.
38.

Absence of cholesterogenesis regulation in the liver and prostate of the BIO 87.20 hamster.

Schaffner CP, Brill DR, Singhal AK, Bonner DP, Goldstein NI, Wang GM.

Lipids. 1981 Nov;16(11):835-40.

PMID:
7311743
39.

A novel cell line isolated from the murine olfactory mucosa.

Goldstein NI, Quinn MR.

In Vitro. 1981 Jul;17(7):593-8. No abstract available.

PMID:
7327592
40.

Surface properties of normal, transformed, and temperature-sensitive rat liver epithelial cells.

Goldstein NI, Fisher PB.

J Natl Cancer Inst. 1981 Mar;66(3):501-8.

PMID:
6937707
41.

Surface properties of normal and adenovirus-transformed rat embryo cells.

Goldstein NI, Fisher PB.

J Cell Sci. 1980 Oct;45:87-97. No abstract available.

42.

Glycoproteins of nuclear polyhedrosis viruses.

Goldstein NI, McIntosh AH.

Arch Virol. 1980;64(2):119-26.

PMID:
6992745
43.

Phenotypic properties and tumor promotor-induced alterations in rat embryo cells transformed by adenovirus.

Fisher PB, Goldstein NI, Weinstein IB.

Cancer Res. 1979 Aug;39(8):3051-7. No abstract available.

44.
46.

Selecting somatic cell hybrids with hat media and nystatin methyl ester.

Fisher PB, Sisskin EE, Goldstein NI.

J Cell Sci. 1978 Aug;32:433-9.

47.

Selection of mouse X hamster hybrids using HAT medium and a polyene antibiotic.

Goldstein NI, Fisher PB.

In Vitro. 1978 Feb;14(2):200-6.

PMID:
352913
48.

Effect of polyene macrolide antibiotics on invertebrate tissue culture cells.

Goldstein NI, Fisher PB, Schaffner CP.

J Antibiot (Tokyo). 1977 Apr;30(4):321-5.

49.

In vitro anti-mycoplasmal activity of amphotericin B methyl ester.

Goldstein NI, McIntosh AH, Fisher PB, Maramorosch K, Schaffner CP.

J Antibiot (Tokyo). 1976 Jun;29(6):656-61.

50.

The effect of fetal bovine serum on polyene macrolide antibiotic cytotoxicity and antifungal activity.

Bonner DP, Fisher PB, Goldstein NI, Mechlinski W, Bryson V, Schaffner CP.

In Vitro. 1976 May;12(5):399-404.

PMID:
780260

Supplemental Content

Loading ...
Support Center